Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 11,441 shares at $39.26 ($452K) on 2016-02-29, disclosed to the SEC on 2016-03-02.
Scheduled sale ($452k) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.26 | 1,340 | $53K | 11.6% |
| 2 | $39.27 | 62 | $2K | 0.5% |
| 3 | $39.52 | 10,039 | $397K | 87.8% |
| Total | $39.49 avg | 11,441 | $452K | 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |